---
figid: PMC3003198__2800fig8
figtitle: Scheme illustrating the dynamic reciprocity between MMP9 and the Raf–MEK–ERK
  pathway, which determines whether cells would continue to proliferate or undergo
  acinar morphogenesis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC3003198
filename: 2800fig8.jpg
figlink: /pmc/articles/PMC3003198/figure/F8/
number: F8
caption: Scheme illustrating the dynamic reciprocity between MMP9 and the Raf–MEK–ERK
  pathway, which determines whether cells would continue to proliferate or undergo
  acinar morphogenesis. Culture of HMECs on 3D lrECM allows formation of polarized
  acini and reduction in proliferation. Increased Raf–MEK–ERK pathway induces MMP9
  expression, which in turn prevents the formation of basal polarity by promoting
  the remodeling of the BM through the proteolysis of LM1. Inhibition of MMP9 activity
  with chemical inhibitors (GM6001 or Marimastat) or shutting down MMP9 expression
  directly with shRNA allows acinar polarization. Down-modulation of the MAPK pathway
  directly with shRNA to MEK1/2 or indirectly by inhibition of EGFR (AG1478) or PI3K
  (LY294002) allows the cells to integrate the proper signaling pathways and promotes
  acinar polarization. The result of proper modulation of the MAPK signaling pathway
  during acinar formation is to reduce the levels of MMP9, thereby protecting the
  integrity of ECM proteins, feeding back the appropriate signals to maintain tissue
  homeostasis. (RTKs) Receptor tyrosine kinases; (mRTKLs) membrane-bound RTK ligands;
  (sRTKLs) soluble RTKLs.
papertitle: Raf-induced MMP9 disrupts tissue architecture of human breast cells in
  three-dimensional culture and is necessary for tumor growth in vivo.
reftext: Alain Beliveau, et al. Genes Dev. 2010 Dec 15;24(24):2800-2811.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9156344
figid_alias: PMC3003198__F8
figtype: Figure
redirect_from: /figures/PMC3003198__F8
ndex: 52a1b715-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3003198__2800fig8.html
  '@type': Dataset
  description: Scheme illustrating the dynamic reciprocity between MMP9 and the Raf–MEK–ERK
    pathway, which determines whether cells would continue to proliferate or undergo
    acinar morphogenesis. Culture of HMECs on 3D lrECM allows formation of polarized
    acini and reduction in proliferation. Increased Raf–MEK–ERK pathway induces MMP9
    expression, which in turn prevents the formation of basal polarity by promoting
    the remodeling of the BM through the proteolysis of LM1. Inhibition of MMP9 activity
    with chemical inhibitors (GM6001 or Marimastat) or shutting down MMP9 expression
    directly with shRNA allows acinar polarization. Down-modulation of the MAPK pathway
    directly with shRNA to MEK1/2 or indirectly by inhibition of EGFR (AG1478) or
    PI3K (LY294002) allows the cells to integrate the proper signaling pathways and
    promotes acinar polarization. The result of proper modulation of the MAPK signaling
    pathway during acinar formation is to reduce the levels of MMP9, thereby protecting
    the integrity of ECM proteins, feeding back the appropriate signals to maintain
    tissue homeostasis. (RTKs) Receptor tyrosine kinases; (mRTKLs) membrane-bound
    RTK ligands; (sRTKLs) soluble RTKLs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Rpl23a-ps9
  - Mmp9
  - Pten
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Akt1
  - Map2k1
  - Mapk3
  - Mapk1
  - MMP9
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - AKT2
  - AKT3
  - MAP2K1
  - MAPK3
  - MAPK1
  - Pik3cg
  - mid
  - LanB1
  - LanA
  - LanB2
  - Tie
  - Ras85D
  - InR
  - scb
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Ras64B
  - Raf
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - rl
  - as
  - Ly294002
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
